Bolt Biotherapeutics BOLT
NASDAQ BOLT
$4.19 +0.01 (+0.17%)
As of: Oct 21, 2026 · 3:56 PM EDT

Bolt Biotherapeutics (BOLT) Other Operating Expenses (2024 - 2026)

Updated

Bolt Biotherapeutics (BOLT) posted Other Operating Expenses of $808,000 for Q2 2026.

Analysis

Bolt Biotherapeutics (BOLT) Other Operating Expenses (2024 - 2026) Analysis & Trends

For FY2024, Bolt Biotherapeutics' Other Operating Expenses came in at $1.47 million.

  • The Q2 2026 figure stands as the highest quarterly Other Operating Expenses since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Bolt Biotherapeutics 8.06 Mn -10.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 808,000.00
Dec 31, 2024 1.47 Mn
API Access

Bolt Biotherapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BOLT&period=max&api_key=YOUR_API_KEY